It is notable that the receptors for this pathway are two lipoprotein receptors, VLDLR (Very Low Density Lipoprotein Receptor) and ApoER2 (Apolipoprotein E2 Receptor), the latter of which has been implicated in Alzheimer’s disease [39]. This evidence concerns the gene VLDLR and Alzheimer disease.